Annual Revenue
$18.60 K
-$129.20 K-87.42%
September 30, 2024
Summary
- As of February 12, 2025, SONN annual revenue is $18.60 thousand, with the most recent change of -$129.20 thousand (-87.42%) on September 30, 2024.
- During the last 3 years, SONN annual revenue has fallen by -$465.00 thousand (-96.15%).
- SONN annual revenue is now -96.15% below its all-time high of $483.60 thousand, reached on September 30, 2021.
Performance
SONN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- SONN quarterly revenue is not available.
Performance
SONN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- SONN TTM revenue is not available.
Performance
SONN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
SONN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.4% | - | - |
| 3 y3 years | -96.2% | - | - |
| 5 y5 years | - | - | - |
SONN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.2% | at low | ||||
| 5 y | 5-year | -96.2% | at low | ||||
| alltime | all time | -96.2% | at low |
Sonnet BioTherapeutics Holdings Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $18.60 K(-87.4%) | - | - |
| Dec 2023 | - | $18.60 K(-50.1%) | $129.20 K(-12.6%) |
| Sep 2023 | $147.80 K(-57.8%) | $37.30 K(+1.1%) | $147.90 K(-14.7%) |
| Jun 2023 | - | $36.90 K(+1.4%) | $173.40 K(-12.7%) |
| Mar 2023 | - | $36.40 K(-2.4%) | $198.60 K(-22.9%) |
| Dec 2022 | - | $37.30 K(-40.6%) | $257.50 K(-26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | $349.90 K(-27.6%) | $62.80 K(+1.1%) | $350.00 K(-54.6%) |
| Jun 2022 | - | $62.10 K(-34.8%) | $770.80 K(+8.8%) |
| Mar 2022 | - | $95.30 K(-26.6%) | $708.70 K(+15.5%) |
| Dec 2021 | - | $129.80 K(-73.2%) | $613.40 K(+26.8%) |
| Sep 2021 | $483.60 K | $483.60 K(-91.5%) | $483.60 K(-91.5%) |
| Mar 2020 | - | $5.68 M | $5.68 M |
FAQ
- What is Sonnet BioTherapeutics Holdings annual revenue?
- What is the all time high annual revenue for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual revenue year-on-year change?
- What is the all time high quarterly revenue for Sonnet BioTherapeutics Holdings?
- What is the all time high TTM revenue for Sonnet BioTherapeutics Holdings?
What is Sonnet BioTherapeutics Holdings annual revenue?
The current annual revenue of SONN is $18.60 K
What is the all time high annual revenue for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual revenue is $483.60 K
What is Sonnet BioTherapeutics Holdings annual revenue year-on-year change?
Over the past year, SONN annual revenue has changed by -$129.20 K (-87.42%)
What is the all time high quarterly revenue for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly revenue is $5.68 M
What is the all time high TTM revenue for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM revenue is $5.68 M